top of page

Home > Specialists > Hematology > Dr. Minghui Duan (段明辉)

Dr. Shijing Deng - Ophthalmologist - Beijing Tongren Hospital Beijing

Specialty & Clinical Focus:

Hematologist and Chief Physician at Peking Union Medical College Hospital in Beijing, with clinical expertise in chronic myeloid leukemia (CML), myeloproliferative neoplasms (MPNs), myelodysplastic syndromes (MDS), lymphoma, leukemia, hematopoietic stem cell transplantation, and rare or refractory blood disorders.

Professional Title & Qualifications:

  • Chief Physician,

  • Professor,

  • M.D.,

  • Ph.D.

Hospital & Department:

Peking Union Medical College Hospital (PUMCH) – Department of Hematology (Note: PUMCH is consistently ranked as the #1 hospital in China)

(address: No. 1 Shuaifuyuan, Dongdan, Dongcheng District, Beijing, 100730)

Dr. Minghui Duan (段明辉) – Renowned Hematologist at Peking Union Medical College Hospital

Personal Biography

Dr. Minghui Duan is a Chief Physician and Professor in the Department of Hematology at Peking Union Medical College Hospital (PUMCH) in Beijing. With more than three decades of clinical experience, his work focuses on complex hematological disorders, including CML, MPNs, MDS, lymphoma, leukemia, hematopoietic stem cell transplantation, and rare or refractory blood diseases. He graduated from Sun Yat-sen University of Medical Sciences in 1994 and earned his Doctor of Medicine degree from Peking Union Medical College in 2008. Dr. Duan also serves as a Master's supervisor and holds leadership and expert committee roles in Chinese hematology organizations.

Why Choose Dr. Minghui Duan (via MedBridgeNZ)

Dr. Minghui Duan brings more than three decades of clinical experience to complex hematological disorders at Peking Union Medical College Hospital in Beijing. His clinical and research work covers chronic myeloid leukemia (CML), myeloproliferative neoplasms (MPNs), myelodysplastic syndromes (MDS), lymphoma, leukemia, hematopoietic stem cell transplantation, and selected rare or refractory blood diseases.


For international patients, a structured remote specialist review can be a practical first step before deciding whether to travel to China. A well-organized case file—including diagnostic reports, laboratory trends, pathology findings, prior treatment history, current medications, and priority questions—helps Dr. Duan review the case efficiently and provide a focused opinion, recommendations, and answers.

  • Complex-case focus: Relevant for patients seeking an experienced hematologist's perspective on chronic, rare, or difficult-to-manage blood disorders.

  • Academic and research depth: His work includes targeted therapies, stem cell transplantation, CML, MPN, MDS, lymphoma, leukemia, and Langerhans cell histiocytosis.

  • Pre-travel clarity: A remote review can help patients understand the specialist's opinion and recommended next steps before arranging an in-person pathway in Beijing.

Pre-Travel Case Review & Specialist Liaison

Before committing to international travel, patients can request MedBridgeNZ coordination for a remote specialist review with Dr. Minghui Duan, Chief Physician and Professor of Hematology at Peking Union Medical College Hospital. MedBridgeNZ organizes the case file, coordinates medical-record translation and client-authorized document transfer, and manages appointment communication with the relevant specialist office.


Once the Dr. Duan review pathway is confirmed, he will review the submitted records, provide a specialist opinion and recommendations, and address the patient's priority questions. This gives patients a clearer basis for deciding whether to pursue an in-person pathway in Beijing and which medical-travel arrangements may be required. The coordination scope and fee are confirmed before work begins.

Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.

Secure a Remote Case Review with

Dr. Minghui Duan

Areas of Expertise

  • Chronic Myeloid Leukemia (CML) & Myeloproliferative Neoplasms (MPN)

  • Myelodysplastic Syndromes (MDS)

  • Lymphoma and Leukemia Management

  • Hematopoietic Stem Cell Transplantation

  • Rare Disorders: Castleman Disease, POEMS Syndrome

  • Diagnosis of difficult and refractory hematological diseases

Verified Client Satisfaction Metrics

⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating

* Treatment Pathway Satisfaction:

5.0/5.0

* Communication & Professionalism:

5.0/5.0

* High demand: Chosen online for specialist liaison and case reviews by over:

26,900 clients

(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)

Work Experience

  • Chief Physician & Professor: Department of Hematology, Peking Union Medical College Hospital (Present)

  • Master's Supervisor: Peking Union Medical College

  • Attending Physician to Chief Physician: PUMCH (Career progression since 1990s)

Education & Training

  • Graduated from Sun Yat-sen University of Medical Sciences (1994)

  • Doctor of Medicine degree, Peking Union Medical College (2008)

Awards & Honors

Academic & Professional Memberships

  • Vice Chairman, Youth Committee of the Hematology Branch of the Beijing Medical Association

  • Vice Chairman, MPN/MDS Branch of the China Medical Education Association

  • Committee Member, Hematopoietic Stem Cell Application Group (Chinese Medical Association)

  • Expert Committee Member, Chinese MDS and MPN Working Group (China Anti-Cancer Association)

  • Expert Committee Member, Anti-Leukemia Alliance (CSCO)

Research & Publications

  • Research Focus: Dr. Duan is dedicated to the clinical and basic research of hematopoietic stem cell transplantation, lymphoma, leukemia, MPN, and MDS.

  • Key Contributions: He has led critical studies on targeted therapies for CML and Langerhans Cell Histiocytosis (LCH).

  • Publications: He has published numerous influential papers in reputable medical journals, contributing significantly to the advancement of hematology in China.

Selected Peer-Reviewed Publications

Selected peer-reviewed publications by Dr. Minghui Duan:

  • Duan M et al. Emerging Significance and Implications of a Durable Complete Molecular Remission in the Treatment of Polycythemia Vera. Curr Hematol Malig Rep. 2025;20(1):13. PMID: 41060606

  • Yang Y et al. Safety and efficacy of flumatinib as later-line therapy in patients with chronic myeloid leukemia. Haematologica. 2024;109(12):3965–3974. PMID: 38934064

  • Lin H et al. Long-term follow-up of methotrexate and cytarabine in adult patients with Langerhans cell histiocytosis. Br J Haematol. 2025;206(2):576–584. PMID: 39428688

*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.

Frequently Asked Questions (FAQs)

Is Dr. Minghui Duan the right hematologist for my condition?


Dr. Duan's documented clinical focus includes CML, MPNs, MDS, lymphoma, leukemia, hematopoietic stem cell transplantation, and rare or refractory hematological disorders. MedBridgeNZ can coordinate a remote specialist-review pathway and prepare the case file for his review. Once the pathway is confirmed, Dr. Duan will review the submitted records, provide his opinion and recommendations, and answer the patient's priority questions. This pre-travel step helps clarify whether his expertise is relevant to the case and what next steps he recommends before the patient makes travel arrangements.


How can international patients request an appointment with Dr. Duan at PUMCH?


MedBridgeNZ coordinates appointment requests and communication with Peking Union Medical College Hospital or the relevant specialist office. We organize medical records, coordinate translation, transfer client-authorized documents, and keep the patient informed throughout the scheduling process. A remote specialist review can be arranged as the first step once the pathway is confirmed, allowing Dr. Duan to examine the submitted case and provide an opinion before an in-person visit is considered. Any on-site appointment remains subject to the hospital's scheduling process and Dr. Duan's availability.


What coordination support is available if I travel to Beijing for an in-person visit?


After the remote review, patients who decide to pursue an in-person pathway can request medical-travel coordination from MedBridgeNZ. Support can include appointment communication, medical invitation or visa-document coordination, travel planning, accommodation coordination, translation coordination, and non-clinical bilingual administrative support in China. The scope and MedBridgeNZ coordination fee are confirmed in writing before work begins. Hospital, specialist, diagnostic, treatment, medication, travel, and other third-party costs remain separate unless a written quotation expressly states otherwise.

Flexible Ways to Connect with the Specialist

We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:

  • Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.

  • On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.

  • In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.

How MedBridgeNZ Helps You:

MedBridgeNZ is a medical concierge and logistics coordination provider for international patients seeking specialist-care pathways in China. We support appointment request coordination, medical-record preparation, translation coordination, client-authorized document transfer, medical invitation or visa-document coordination, travel planning, accommodation coordination, and non-clinical bilingual administrative support. MedBridgeNZ does not provide medical advice, diagnosis, or treatment. Specialist, hospital, diagnostic, treatment, medication, travel, and other third-party costs remain separate from MedBridgeNZ coordination fees unless expressly stated in writing.

bottom of page